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Biochemical studies suggest that excitatory neu-
rons are metabolically coupled with astrocytes to
generate glutamate for release. However, the extent
to which glutamatergic neurotransmission depends
on this process remains controversial because direct
electrophysiological evidence is lacking. The dis-
tance between cell bodies and axon terminals pre-
dicts that glutamine-glutamate cycle is synaptically
localized. Hence, we investigated isolated nerve ter-
minals in brain slices by transecting hippocampal
Schaffer collaterals and cortical layer I axons. Stimu-
lating with alternating periods of high frequency
(20 Hz) and rest (0.2 Hz), we identified an activity-
dependent reduction in synaptic efficacy that corre-
lated with reduced glutamate release. This was
enhanced by inhibition of astrocytic glutamine syn-
thetase and reversed or prevented by exogenous
glutamine. Importantly, this activity dependence
was also revealed with an in-vivo-derived natural
stimulus both at network and cellular levels. These
data provide direct electrophysiological evidence
that an astrocyte-dependent glutamate-glutamine
cycle is required to maintain active neurotransmis-
sion at excitatory terminals.
INTRODUCTION
Synaptic transmission requires a continuous supply of neuro-
transmitter for release. Althoughmost typesof neurons usedirect
reuptake to recycle released neurotransmitters, evidence indi-
cates that glutamatergic synapses rely predominantly on
astrocytes for generation and recycling of glutamate (Hertz,
1979). Biochemical studies demonstrate that astrocytes take
up glutamate and convert it to glutamine, which is released into
the extracellular space and taken up by neurons as a glutamate
precursor in what is known as the glutamate-glutamine cycle.
The cycle is generated by a segregated expression pattern for
key molecular components. Astrocytes express high-affinity888 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.excitatory amino acid transporters that clear released glutamate
from the synapse, alongwith glutamine synthetase (GS) that con-
verts glutamate to glutamine, and transporters that release gluta-
mine into the extracellular space. In a reciprocal fashion, neurons
express transporters that mediate uptake of glutamine, phos-
phate-activated glutaminase that converts glutamine back to
glutamate, and the machinery necessary for packaging and
releasing glutamate through vesicle exocytosis (Danbolt, 2001).
This model of cellular cooperation and compartmentalization
predicts that efficacy at glutamatergic synapses is coupled to
both astrocytic and neuronal metabolism. However, attempts
to define a role for the glutamate-glutamine cycle in regulating
excitatory synaptic transmissionwith standard electrophysiolog-
ical analysis have met with limited success (Kam and Nicoll,
2007; Masson et al., 2006). In fact, a requirement for the cycle
has only been demonstrated during epileptiform activity, a dis-
ease setting in which glutamate release is greatly increased
(Bacci et al., 2002; Otsuki et al., 2005; Tani et al., 2010).
Studies in living animals have demonstrated that 70% of
synaptic glutamate is derived from the glutamate-glutamine
cycle (Kvamme, 1998; Lieth et al., 2001; Rothman et al., 2003;
Sibson et al., 2001). How can these in vivo studies be reconciled
with electrophysiological analyses of isolated brain slices that
suggest that glutamatergic neurotransmission can be sustained
in the absence of the glutamate-glutamine cycle (Kam andNicoll,
2007; Masson et al., 2006)? We reasoned that the lack of direct
evidence for its requirement reflects the absence of an appro-
priate system in which to test this. For excitatory neurons with
long axonal projections, the physical distance between the
neuronal cell body and the presynaptic terminal limits the contri-
bution of somatic sources to the pool of glutamate available for
synaptic release. This suggests that a perisynaptic localization
of the glutamate-glutamine cycle would be required for maintain-
ing high-frequency neurotransmitter release from these neurons.
We therefore investigated glutamate release from isolated nerve
terminals by taking advantage of the anatomy of two well-
defined projection neuron tracts in the hippocampus and the
cortex. By acutely transecting the axons, we separated excit-
atory nerve terminals from their cell bodies while retaining the
relationship of presynaptic structures with postsynaptic neurons
and surrounding astrocytes. We found that these isolated termi-
nals provide a reliable system for electrophysiological analysis
of the role of the glutamate-glutamine cycle in excitatory
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glutamate release could be sustained in the absence of the
glutamate-glutamine cycle, but not indefinitely, suggesting that
there is a reservoir of glutamate and/or glutamine. Using a stim-
ulation paradigm with alternating periods of robust activity and
rest, we identified an activity-dependent reduction in synaptic
efficacy that correlated with a reduction in glutamate release.
The reduced efficacy was greater with inhibition of astrocytic
GS and fully reversed or prevented by addition of glutamine. Sur-
prisingly, the rate of recovery did not differ in untransected slices,
suggesting that in an intact brain, a local glutamate-glutamine
cycle is the predominant pathway for excitatory neurotransmitter
recycling. Furthermore, natural stimulation patterns derived from
in vivo recordings resulted in a similar glutamine-responsive
activity-dependent reduction in synaptic efficacy. This was
observed at the level of individual synapses with minimal stimu-
lationwhile recording intracellularly fromCA1 neurons. Together,
these findings demonstrate a role for a synaptically localized
glutamate-glutamine cycle in maintaining excitatory neurotrans-
mitter synthesis and vesicle release during periods of robust
activity.
RESULTS
To study the role of the glutamate-glutamine cycle in the release
of neurotransmitter from axotomized terminals, we first focused
on the Schaffer collateral pathway in the hippocampus. Synap-
ses of the Schaffer collateral pathway are among themost exten-
sively studied in the mammalian brain, and the well-delineated
structure of the hippocampus permits simple isolation of the pre-
synaptic Schaffer collateral axons from their CA3 cell bodies
while retaining the structural relationship of the presynaptic bou-
ton with the postsynaptic structures and perisynaptic astro-
cytes. Furthermore, bursts of 20–30 Hz activity lasting more
than a minute have been observed in the mouse hippocampus
during novel environment exploration (Berke et al., 2008). Thus,
Schaffer collateral fibers release and must recycle or synthesize
large amounts of glutamate to sustain such activities. Studies
in vitro have also demonstrated that stimulation of Schaffer
collateral fibers at 20 Hz drives excitatory neurotransmission at
a maximal rate and exhausts the readily releasable pool of ves-
icles in 3 s (Dobrunz and Stevens, 1997; Garcia-Perez et al.,
2008; Stevens and Wesseling, 1999; Wesseling and Lo, 2002).
Beyond this time point, a steady state of vesicle recycling is
established, and the rate of neurotransmitter replenishment
can define the sustained rate of release. With addition of
N-methyl-D-aspartate (NMDA) receptor antagonists to block
long-lasting plasticity, this experimental system allows for a
direct electrophysiological analysis of the role of neurotrans-
mitter synthesis in excitatory neurotransmission.
In hippocampal slices with Schaffer collateral fibers trans-
ected and perfused with standard artificial cerebrospinal fluid
(aCSF), we established a stable baseline of evoked field excit-
atory postsynaptic potentials (fEPSPs) in the stratum radiatum
with 0.2 Hz stimulation. A baseline was typically obtained within
10–15min, and the fEPSPs remained stable for more than 60min
(Figure 1A, left panel). To test whether the capacity to release
glutamate for extended periods of time depends upon the gluta-mate-glutamine cycle, we preincubated slices with methionine
sulfoximine (MSO), an irreversible inhibitor of the astrocytic
enzyme GS. GS is required for both the glutamate-glutamine
cycle and synthesis of glutamine derived de novo through ana-
plerosis (Schousboe et al., 1993). With a stimulation frequency
of 0.2 Hz, the fEPSPs in theMSO-pretreated slices remained sta-
ble for 60 min (Figure 1A, right panel), consistent with previous
findings (Kam and Nicoll, 2007; Masson et al., 2006). However,
with the stimulation frequency increased to 2 Hz, after about
1,000 stimuli, there was a progressive reduction in fEPSP ampli-
tudes in MSO-treated slices (Figure 1B, black trace). To confirm
that this effect was due to inhibition of GS, we added 500 mM
glutamine, a concentration in the physiological range (Moore
et al., 1978). This mitigated the effect of MSO (Figure 1B, green
trace and right panels), indicating that there is a reservoir of
glutamate and/or metabolic precursors that can sustain activity
during prolonged periods of low-frequency activity but can be
depleted by periods of more robust activity.
The experiments with MSO-treated slices indicated that the
glutamate-glutamine cycle is necessary for sustained excitatory
neurotransmission during prolonged periods of activity. We
wondered whether the demand on an intact glutamate-gluta-
mine cycle might be exceeded by its capacity during robust
activity. Assaying slices not treated with MSO and increasing
the stimulation rate to 20Hz, we found that the fEPSP amplitudes
initially increased and then rapidly decreased to the point of
being nearly undetectable (Figure 1C, black tracing). If this was
due to loss of glutamate and/or its metabolic precursor gluta-
mine in the effluate, then supplementation with glutamine should
attenuate the loss of synaptic transmission. With addition of
500 mM glutamine, the initial increases and decreases in fEPSP
amplitudes were similar to those in control slices during the first
1,000 pulses (50 s), but after that, the relative fEPSP ampli-
tudes were greater than those in control slices and remained sta-
ble for the duration of the experiment (Figure 1C, green tracing).
This indicates that, in the presence of glutamine, synaptic trans-
mission at isolated Schaffer collateral terminals can be main-
tained during prolonged periods of high-frequency stimulation.
The rapid decline in postsynaptic responses seen with 20 Hz
stimulation in the presence of glutamine likely reflects high-fre-
quency-induced short-term synaptic depression caused by a
limited availability of release-ready vesicles (Dobrunz and Ste-
vens, 1997; Sara et al., 2002; Stevens and Wesseling, 1999).
We reasoned that a pattern of high-frequency stimulation alter-
nating with periods of low-frequency stimulation might allow
readily releasable vesicle pools to be replenished without neces-
sarily allowing neurotransmitter levels to recover fully. This could
lead to more neurotransmitter release over time and place a
greater demand on glutamate supply sources. Therefore, we
used a stimulation protocol interleaving high-frequency stimuli
(HFS; 20 Hz) for 50 s (1,000 pulses) with low-frequency stimuli
(LFS; 0.2 Hz) for 200 s (40 pulses), hereafter referred to as inter-
mittent high-frequency stimulation (iHFS) protocol. We chose
50 s for the HFS interval both because this is the point at which
we started to see an effect with glutamine in the continuous
HFS paradigm, and because this is within the range of physio-
logical bursts of high-frequency activity in the hippocampus
(Berke et al., 2008). With the iHFS protocol, we are also able toNeuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc. 889
Figure 1. Glutamine Prevents fEPSP
Depression during High-Frequency Repeti-
tive Stimulation of the Schaffer Collaterals
(A) Example traces at baseline (black) and after
60 min (red) of continuous 0.2 Hz stimulation
(upper) and paired plot of fEPSP amplitudes
(lower) for untreated slices (left) and slices pre-
treated with MSO to inhibit GS (right). N.S., not
significant.
(B) Time course of relative fEPSP area during
continuous 2 Hz stimulation (4,000 stimuli;
33.3 min) of the Schaffer collaterals (left panel) in
slices treated with MSO in aCSF (black; n = 6) and
with addition of 500 mM glutamine (green; n = 6).
Evoked fEPSP amplitudes during 0.2 Hz stimula-
tion at baseline and at 40 min (6 min after 2 Hz
stimulation) show significant fEPSP depression
(Student’s t test, p < 0.0005) in MSO-treated sli-
ces, but not in glutamine (right panel).
(C) Time course of continuous 20 Hz stimulation of
Schaffer collaterals in aCSF (black; n = 6) and with
glutamine (green, n = 4). Inset shows example
traces at indicated stimulus numbers. Gray bars
indicate SEM.
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Glu/Gln Cycle Sustains Excitatory Transmissionanalyze synaptic activity during the periods of LFS, without
confounding factors associated with high-frequency stimulation
such as changes in releasable vesicle pool size (Dobrunz and
Stevens, 1997; Sara et al., 2002; Stevens and Wesseling,
1999). With iHFS, we again found a decrease in the evoked
fEPSP amplitudes during 20Hz stimulation but also a further pro-
gressive decrease with subsequent HFS iterations (Figure 2A,
left panel). When slices were treated with glutamine, there was
also a decrease in the fEPSP amplitudes during 20 Hz stimula-
tion train but full recovery between HFS iterations (Figure 2A,
right panel). The time course of fEPSPs demonstrates a robust890 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.cumulative glutamine-sensitive reduction
in fEPSPs with iHFS that persisted for
more than 5 min after termination of the
final 20 Hz iteration (Figure 2B, left panel
upper tracings and right panel). In the
glutamine-treated slices, the fEPSPs
rapidly recovered to baseline at 0.2 Hz
after HFSs. This suggests that vesicle
pools are replenished quickly during
LFS and that in the absence of gluta-
mine, the incomplete recovery was
due to depletion of glutamate available
for neurotransmission. Interestingly, the
reduction in fEPSP amplitudes with iHFS
and subsequent recovery during low-
frequency stimulation were similar in
transected and intact hippocampal slices
(Figure S1 available online). The fEPSP
amplitudes remained reduced by more
than half in both groups even 5 min after
iHFS was completed.
Although we suspected that limited
neurotransmitter supply was the primarycause for the reduced fEPSPs after prolonged high-frequency
activity, another possible explanation was that the efficacy with
which electrical stimulation elicited an action potential waned.
To determine whether this contributed to the reduced synaptic
signaling, we examined fiber volleys (FVs) during the periods of
0.2 Hz stimulation. Aside from transient suppression during
HFSs, FVs were stable over the course of the experiment and
were not affected by glutamine (Figure 2B, left panel lower trac-
ings; Figure S2), indicating that there were no long-term changes
in intrinsic excitability of the stimulated fibers by iHFS or by
glutamine.
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Figure 2. iHFS Causes Use-Dependent
fEPSP Depression that Is Prevented by
Glutamine
(A) Evoked fEPSP amplitudes during intermittent
20 Hz stimulation with four iterations of 1,000
pulses at 20 Hz separated by 200 s of recovery at
0.2 Hz in aCSF (left panel; n = 8) and aCSF with
500 mM glutamine (right panel; n = 5). Gray bars
indicate SEM.
(B) Time course of fEPSP amplitude (upper left)
and FV amplitude (lower left) during iHFS protocol
on slices in aCSF (black) and aCSF with glutamine
(green). Traces of evoked fEPSP during 0.2 Hz
stimulation at baseline (B), after successive itera-
tions of 1,000 pulses at 20 Hz (1–4), and after a
subsequent 5 min recovery period (R) of 0.2 Hz
stimulation (middle panel) and summary (right
panel; n = 9, two-way repeated-measures ANOVA
with Bonferroni posttest, ***p < 0.001; error bars
represent 95% CI) demonstrate activity-depen-
dent reduction in fEPSP amplitude. FV and fEPSP
are indicated by the arrowhead and arrow,
respectively, in baseline sample tracings in (B).
Scale bars, 10 ms and 0.5 mV (middle panel).
(C) Graphs of input (FV amplitude in mV) and
output (relative fEPSP slope) are plotted for stim-
ulated (iHFS) electrodes with control stimulation
pathway (continuous 0.2 Hz stimulation) shown in
insets. I/O curves before iHFS (blue) and after (red)
in the absence (left) and presence (right) of gluta-
mine are shown (two-way repeated-measures
ANOVA with Bonferroni posttest, **p < 0.01 and
***p < 0.001; error bars represent 95% CI). The
same recording electrode was used for iHFS and
control-stimulating electrodes.
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Glu/Gln Cycle Sustains Excitatory TransmissionWe next sought to ensure that the glutamine-responsive
reduction in fEPSP amplitude did not reflect diffuse metabolic
changes in the slice. To assess this, we compared input-output
(I/O) curves from two laterally displaced stimulating electrodes,
with one site stimulated as above with the iHFS protocol and
the other (control) assessed continuously at 0.2 Hz, while
recording from a single central recording electrode. With the
iHFS protocol, there was a significant depression (rightward
shift) of the I/O curve, especially for small-to-moderate FV ampli-
tudes. This shift was not noted for the control electrode (Fig-
ure 2C, left panel) or for either electrode with slices incubated
with glutamine (Figure 2C, right panel), suggesting that the
effects of iHFS and glutamine are limited to the synapses that
have been activated.
To determine how long this effect of high-frequency activity on
synaptic efficacy would last, we monitored fEPSPs during an
extended recovery period. We found that after the iHFS protocol
in aCSF, therewas a slow recovery of fEPSP amplitudes that was
still incomplete after 20 min (Figures 3A and 3B). With subse-
quent addition of glutamine, the recovery of fEPSP amplitudeNeuron 81, 888–900,appeared to be hastened and near com-
plete within 20 min. We next compared
recovery during an extended LFS period
after completion of iHFS without and
with glutamine. Without glutamine, therewas little increase in the average relative fEPSP amplitude be-
tween 30 and 60 min after iHFS (0.53 ± 0.30 and 0.59 ± 0.29,
respectively; p = 0.239, paired two-tailed t test). There was, how-
ever, a significant recovery when glutamine was added at the
start of the extended LFS period (0.58 ± 0.22 and 0.82 ± 0.34,
respectively; p = 0.0128, paired two-tailed t test). The addition
of glutamine did not affect the FV but caused normalization of
the I/O curve (Figure 3C), consistent with its specific effect on
the stimulated pathway.
The extent to which endogenous glutamine synthesized by
astrocytes is required for the sustained periods of high-
frequency excitatory synaptic transmission in our system is
unclear, but the reduction in synaptic efficacy caused by the glio-
toxins fluoroacetate and fluorocitrate suggests that astrocytes
are required for themaintenance of excitatory neurotransmission
(Bacci et al., 2002; Bonansco et al., 2011; Keyser and Pellmar,
1994). To test this, we preincubated slices with MSO to inhibit
the astrocytic enzyme GS. We expected that MSO would cause
a more rapid reduction in fEPSP amplitude and that this effect
would be attenuated by the addition of glutamine. We foundFebruary 19, 2014 ª2014 Elsevier Inc. 891
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Figure 3. Glutamine Reverses iHFS-Induced
fEPSP Amplitude Reduction
(A) Time course of fEPSP amplitude (upper trace)
and FV (lower trace) with standard iHFS protocol
followed by addition of glutamine. Traces during
collection of data for I/O relationship were removed
(and depicted by gaps) for clarity. Example traces
during 0.2 Hz stimulation at indicated time points
are depicted on right.
(B) Paired plot of fEPSP amplitude measurement
before and after iHFS protocol (left panel) shows
significant depression at 20 min after the iHFS
(Student’s t test, p < 0.0001) and a corresponding
rightward shift in the I/O curve (right panel). There is
no change in the I/O curve for the control pathway
(inset). Error bars represent 95% CI.
(C) Addition of glutamine 20min after iHFS protocol
significantly increases fEPSP amplitude 20 min
later (left panel; Student’s t test, p = 0.0129). There
is also a corresponding leftward shift of the I/O
curve (right panel). Note that glutamine does not
affect the I/O curve of the control pathway (inset).
For statistical analyses of the I/O curves, two-way
repeated-measures ANOVA with Bonferroni post-
test was applied (**p < 0.01 and ***p < 0.001). Error
bars represent 95% CI.
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Glu/Gln Cycle Sustains Excitatory Transmissionthat pretreatment of slices with MSO had little effect on the
evoked fEPSP amplitudes during the first epoch of 20 Hz stimu-
lation in the iHFS protocol, but with subsequent iterations, the
recovery between HFS trains was much less complete than in
untreated slices—ultimately, fEPSPs were abolished (Figure 4A,
left panel). Even after 20 min of LFS, the fEPSP amplitudes did
not recover in the MSO-treated slices (Figure 4B). With addition
of glutamine to the MSO-treated slices, there was complete and
persistent recovery between iterations of the high-frequency
stimulation and no discernable difference between MSO-treated
slices rescued with glutamine and slices to which glutamine
alone was added (cf. Figure 4A right panel to Figure 2A right
panel). Furthermore, when glutamine was added toMSO-treated
slices after iHFS, there was a complete recovery of fEPSP ampli-892 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.tudes and normalization of I/O curves,
again with no discernable difference with
slices to which glutamine was added
(cf. Figures 4B and 4C to Figures 2B
and 2C). The effect of MSO and its
reversal with glutamine support the hy-
pothesis that astrocyte-derived glutamine
is required for maintaining synaptic trans-
mission during prolonged periods of inter-
mittent high-frequency activity.
Reductions in synaptic efficacy can
occur through a number of different
mechanisms, including changes in post-
synaptic responsiveness (Collingridge
et al., 2010). To confirm that our results
reflect changes in glutamate release, we
used two independent approaches. First,
we used Fo¨rster resonance energy trans-fer (FRET)-based glutamate biosensor imaging to measure
extracellular glutamate transients (Figure 5A). This biosensor is
a chimeric protein composed of cyan fluorescent protein
(CFP) and the yellow fluorescent protein (YFP) variant Venus in-
serted into the N-terminal and C-terminal regions of the bacte-
rial glutamate binding protein YbeJ, respectively. Glutamate
binding causes a conformational change in the protein, which
results in a decrease in FRET efficiency between the CFP and
Venus. The biosensor allows for qualitative measurement of
glutamate release in brain slices throughout an optic field
with temporal resolution in the millisecond scale (Dulla et al.,
2008, 2012). As expected, we found a decrease in glutamate
biosensor signal with evoked release following iHFS, and this
was prevented by glutamine (Figure 5B). As a second approach,
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Figure 4. Inhibiting Glutamine Synthesis
with MSO Enhances iHFS-Induced fEPSP
Depression
(A) Evoked fEPSP amplitudes for MSO-treated
slices during four iterations of 1,000 pulses at
20 Hz separated by 200 s of recovery at 0.2 Hz
in aCSF (left panel; n = 8) and aCSF with
500 mM glutamine (right panel; n = 5). Gray bars
indicate SEM.
(B) Representative time course of evoked fEPSPs
(upper) and FVs (lower) in MSO-treated slice. Note
that adding glutamine after iHFS was associated
with recovery that persisted during an additional
13 HFS iterations. Gaps represent time periods
during which data for the I/O relationship were
being collected. Traces of evoked fEPSP during
0.2 Hz stimulation at baseline (B), after successive
iterations of 1,000 pulses at 20 Hz (1–4), and after
a subsequent 5 min recovery period (R) of
0.2 Hz stimulation (upper-right panel) and sum-
mary (lower-right panel; n = 6, two-way repeated-
measures ANOVA with Bonferroni posttest, *p <
0.05 and ***p < 0.001; error bars represent 95%CI)
demonstrate the reduction in fEPSP in the MSO-
treated slices and the recovery with addition of
glutamine.
(C) I/O curves before iHFS (blue) and after (red) for
MSO-treated slices in the absence (left) and
presence (right) of glutamine (two-way repeated-
measures ANOVA with Bonferroni posttest, **p <
0.01 and ***p < 0.001; error bars represent 95%
CI). Insets show I/O curves for laterally displaced
control electrodes that were stimulated continu-
ously at 0.2 Hz.
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Glu/Gln Cycle Sustains Excitatory Transmissionwe used the competitive AMPA receptor antagonist g-D-gluta-
mylglycine (g-DGG) to assess synaptic glutamate levels (Chris-
tie and Jahr, 2006; Liu et al., 1999). This low-affinity antagonist
has rapid equilibration kinetics with AMPA receptors and com-
petes with glutamate for receptor binding during the glutamate
transient associated with exocytosis. As a result, lower concen-
trations of glutamate are more effectively blocked by g-DGG.
We found that the effect of g-DGG was enhanced even after
only two iterations of HFSs (Figure 5C). In slices pretreated
with MSO, the effect of g-DGG was again enhanced by iHFS,
whereas with addition of glutamine to MSO-pretreated slices,
the efficacy of g-DGG was unchanged by iHFS (Figures 5D
and 5E). Together, the findings with the biosensor and g-DGG
support the conclusion that iHFS leads to a reduction in gluta-Neuron 81, 888–900,mate release and reduced synaptic con-
centrations of glutamate.
Although unfilled synaptic vesicles can
undergo exocytosis, it has been sug-
gested that presynaptic cytosolic trans-
mitter content influences vesicle release
in cholinergic (Poulain et al., 1986) and
GABAergic neurons (Wang et al., 2013).
Because the paired-pulse ratio depends
upon the probability of release (Branco
and Staras, 2009; Hanse and Gustafsson,2001), we examined this after iHFS on MSO-pretreated slices
with and without glutamine. We found an increase in paired-
pulse ratio after iHFS that was prevented by addition of gluta-
mine, suggesting that glutamine influences release probability
at excitatory synapses (Figure S3).
We wondered whether the dependence on the glutamate-
glutamine cycle is shared by other excitatory synapses. To test
this, we established a system for electrophysiological analysis
of neurotransmitter release from isolated layer I axons in the
neocortex (Figure 6A) based on a previously described prepara-
tion by Cauller and Connors (1994). This allowed us to stimulate
the axotomized fibers in layer I and record synaptic responses
from layer III where the pyramidal cells are connected via distal
apical dendrites projecting to layer I. At 0.2 Hz stimulationFebruary 19, 2014 ª2014 Elsevier Inc. 893
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B Figure 5. Reduction in Evoked Glutamate
Release after iHFS Is Prevented by the Addi-
tion of Glutamine
(A) Representative heatmaps of glutamate bio-
sensor FRET change (DFRET) for regions of
interest adjacent to stimulating electrodes in the
Schaffer collaterals overlaid on a bright-field
image. Baseline signal (top panel) was obtained
during an initial period of 0.2 Hz stimulation at both
electrodes. After the left electrode was subjected
to the iHFS protocol (bottom panel), there was a
marked decrease in the signal, whereas there was
little change in the signal at control electrode
stimulated continuously at 0.2 Hz (right electrode).
Scale bars, 200 mm.
(B) Representative time course of evoked FRET
signal change by iHFS electrode in aCSF (upper)
and in glutamine (lower) at baseline (black) and
after iHFS (red). Scale bars, 100 ms; 0.005 DFRET.
Summary of the reduction in evoked peak DFRET
5 min after iHFS with and without glutamine is
presented (n = 4 aCSF, n = 7 glutamine, one-way
ANOVA, **p = 0.002). There were no significant
differences at the control electrode stimulated
with continuous 0.2 Hz in presence and absence
of glutamine (data not shown). Error bars indi-
cate SEM.
(C–E) Effect of low-affinity, fast-equilibrating AMPA
receptor antagonist g-DGG. Example traces and
corresponding paired sample data (analyzed by
Student’s t test) show the effect of 1 mM g-DGG
applied for 6 min (indicated as black bars in traces)
before and after iHFS (left traces) compared to
control electrode (right traces) in the same slice in
(C) aCSF, (D)MSO-pretreated slices, and (E) MSO-
pretreated slices to which glutamine was added.
The bottom number represents the evoked ampli-
tude 5 min after addition of g-DGG, and the top
number represents the evoked amplitude in the
absence of g-DGG, derived from the evoked
amplitudes immediately before and after g-DGG
wash-in. R is the ratio of the amplitude of g-DGG
effect to the baseline amplitude (equal to the
bottom number divided by the top number). The
change in effect of g-DGG was calculated by
determining the change in ratio of amplitude
reduction caused by g-DGG before and after iHFS.
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Glu/Gln Cycle Sustains Excitatory Transmissionfrequency, we saw no reduction in the fEPSP amplitude (Fig-
ure 6B). We therefore again used the iHFS paradigm. Compared
to the hippocampus, the neocortex was more resistant to the
reduction in fEPSP amplitude, requiring up to 13 iterations with
20 Hz stimulation to see a substantial loss of measurable
fEPSPs. As with the hippocampal preparation, the reduction in
fEPSP amplitude was eliminated by addition of glutamine to
the perfusate (Figure 6C) and enhanced by pretreatment with
MSO (Figure 6D).
To determine whether dependence of excitatory neurotrans-
mission on the glutamate-glutamine cycle can be elicited with
naturally occurring neuronal activity, we obtained in vivo unit
recordings representing firing patterns of single CA3 pyramidal
cells from a freely moving rat running laps in a field (courtesy
of Dr. Kenji Mizuseki, Allen Institute for Brain Science, and
Dr. Gyo¨rgy Buzsaki, New York University Neuroscience Insti-894 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.tute). We converted 12 min of continuous recording from two
representative CA3 cells with low activity (natural low-frequency
stimulation [nLFS], mean 0.3 Hz and peak 6 Hz) and high activity
(natural high-frequency stimulation [nHFS], mean 5.4 Hz and
peak 44 Hz) to time-stamped stimulus patterns to drive the stim-
ulators simultaneously on parallel Schaffer collateral fibers. This
duration was chosen because it represented approximately
4,000 pulses for nHFS (4,032), consistent with other experi-
ments. To obtain a baseline and assess recovery, fEPSPs were
evoked at 0.2 Hz before and after the natural stimulus patterns.
nHFS caused almost the same extent of fEPSP run down as
four iterations of iHFS, whereas there was no effect with nLFS
(Figures 7A and 7B). Same-slice comparisons were made by
applying the natural stimulus patterns first in aCSF then with
glutamine added. We found a glutamine-responsive depression
of fEPSP with nHFS, but not with nLFS (Figures 7B and 7C, top
AC
D
B Figure 6. Glutamine Prevents fEPSP
Depression during Repetitive Stimulation
of Layer I Cortical Afferents
(A) Bright-field image of a rat brain slice in which
layer I cortical axons have been transected and
separated from on column deeper layers. Posi-
tions of stimulating (left) and recording electrode
(right; in layer III where layer V apical dendrites
project) are depicted by line drawings. Scale
bar, 1 mm.
(B) Representative time course of evoked fEPSP
amplitude during continuous 0.2 Hz stimulation
protocol (upper) and plot of paired fEPSP ampli-
tude measurements at 5 and 60 min for five slices
stimulated continuously at 0.2 Hz (lower; Student’s
t test, no significant difference).
(C) Representative time course of evoked fEPSP
amplitudes recorded during 0.2 Hz stimulation
period during baseline (B), after 4th (4) and 13th (13)
HFS iteration, and during recovery (R) with sample
traces above (black trace indicates aCSF; green
trace indicates glutamine). Summary of fEPSP
amplitude after each HFS iteration is presented
(right panel; n = 5, two-way repeated-measures
ANOVA with Bonferroni posttest, ***p < 0.001;
error bars represent 95% CI).
(D) As in (C) with slices preincubated with GS
inhibitor MSO.
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Glu/Gln Cycle Sustains Excitatory Transmissionpanels). Furthermore, amplitudes of fEPSPs 10 min after nHFS
(Figure 7C, bottom panel) remained depressed in aCSF
(0.478 ± 0.079) but almost completely recovered in glutamine
(0.975 ± 0.084).
Finally, we evaluated the effects of neurotransmitter depletion
at the synaptic level by repeating the experiments with natural
stimulus patterns using minimal stimulation of Schaffer collat-
eral fibers coupled with intracellular recordings of CA1 cells
to more closely approximate in vivo CA3 neuronal activity.
As with the field recordings, we established a baseline with
0.2 Hz stimulation at both electrodes, followed by 12 min during
which one electrode was stimulated with the nLFS pattern and
the other with the nHFS pattern. This was followed by a return to
0.2 Hz stimulation at both electrodes. Analysis of evoked EPSCs
demonstrates that whereas there was no difference in evoked
amplitudes after nLFS in aCSF or glutamine (Figures 8A and
8B), there was a significant reduction in minimally evoked ampli-
tudes after nHFS in aCSF, but not in glutamine (Figures 8C and
8D). The reduction in EPSC amplitudes with nHFS in aCSF per-
sisted for at least 10 min, consistent with our field recording
results.Neuron 81, 888–900,DISCUSSION
The glutamate-glutamine cycle is a well-
established biochemical pathway, but
direct evidence for its role in the synthesis
of synaptically released glutamate has
been lacking. Indeed, results of previ-
ous physiological studies have argued
against a requirement for the cycle in
excitatory neurotransmission (Kam andNicoll, 2007; Masson et al., 2006). Similar to these previous
studies, we found that with a low-frequency stimulation protocol,
glutamatergic synaptic transmission can persist for extended
periods of time in the absence of a functional glutamate-gluta-
mine cycle even from axotomized synaptic terminals. However,
we found that increasing the stimulation frequency readily un-
covered a requirement for the glutamate-glutamine cycle and
that with both alternating periods of high-frequency and low-fre-
quency stimulation and high-frequency natural stimulus pattern,
the requirement was more apparent.
Our findings with the axotomized preparations indicate that
prolonged high-frequency excitatory neurotransmission can be
sustained by a local synaptic glutamate-glutamine cycle. This
model of a perisynaptic intercellular metabolic pathway is sup-
ported by the subcellular expression of the molecular compo-
nents of the cycle. Endfeet of astrocytes that surround synapses
express the high-affinity glutamate transporters as well as the
system N glutamine transporters that are involved in glutamine
efflux, whereas phosphate-activated glutaminase that converts
glutamine to glutamate is expressed in excitatory axons (Aoki
et al., 1991; Boulland et al., 2002; Danbolt, 2001). Recently,February 19, 2014 ª2014 Elsevier Inc. 895
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Figure 7. In-Vivo-Derived Natural Stimulus
Pattern Reveals Glutamine-Dependent Re-
duction in Evoked fEPSPs
Twelve minutes of in-vivo-derived neuronal firing
patterns were replayed as an nLFS or nHFS on
parallel Schaffer collateral fibers in the absence or
presence of glutamine.
(A) Five seconds of representative field recording
traces near the end of 12 min of nLFS and nHFS
show no difference between aCSF and glutamine
treatment on the same slice with nLFS, but a
significant depression in fEPSP amplitudes with
nHFS that is prevented by glutamine. Stimulus
artifacts were removed for clarity.
(B) Traces of evoked fEPSPs (upper panel) during
0.2 Hz stimulation at baseline (B) and after 5 min
recovery (R) from natural stimulus patterns for sli-
ces perfused first with aCSF (black filled circles,
left) and then with aCSF plus glutamine (green
filled circles, right). Traces of nLFS protocol elec-
trode are in red and those of nHFS protocol elec-
trode in black. Sample time course of relative
fEPSP amplitude (middle panel) and FV amplitude
(lower panel) evoked at 0.2 Hz during baseline
acquisition and after recovery from nLFS (red) and
nHFS (black) protocols initially in aCSF and then
with addition of glutamine is shown. Blue bars
indicate duration of nLFS/nHFS.
(C) Paired analysis of evoked fEPSP amplitudes in
aCSF and aCSF with glutamine 5 min after natural
stimulus protocols (top) revealed no difference in
evoked fEPSP amplitudes after nLFS, but fEPSP
amplitude depression with nHFS in aCSF that was
markedly attenuated in the presence of glutamine
(n = 7, two-way repeated-measures ANOVAwith Bonferroni posttest, p < 0.0001). Relative fEPSP amplitudes remained significantly depressed 10min after nHFS
in aCSF (0.478 ± 0.079; Student’s t test, ***p < 0.0001) but almost completely recovered in the presence of glutamine (0.975 ± 0.084). Error bars indicate SEM.
Neuron
Glu/Gln Cycle Sustains Excitatory Transmissioncoupling of glutamate uptake and glutamine release by astro-
cytes has been elegantly demonstrated by Uwechue et al.
(2012). Billups and colleagues showed that uptake of glutamate
released from neurons can trigger synthesis and release of gluta-
mine from perisynaptic astrocytes (Uwechue et al., 2012). Our
findings provide direct evidence for the other half of the gluta-
mate-glutamine cycle in neurotransmitter metabolism, i.e., utili-
zation of glutamine by neurons for synthesis of synaptically
released glutamate. Interestingly, Billups and colleagues de-
tected glutamine release by measuring electrogenic glutamine
uptake into the postsynaptic MNTB neuron at the Calyx of
Held (Uwechue et al., 2012). Because these neurons are
GABAergic, their findings indicate that glutamine derived from
synaptically released glutamate can serve as the precursor for
the inhibitory neurotransmitter that modulates the excitatory
network activity (Fricke et al., 2007; Liang et al., 2006). After
this manuscript was submitted, Billups and colleagues have
demonstrated that inducible presynaptic glutamine transport
supports glutamatergic transmission at the calyx of Held syn-
apse (Billups et al., 2013), providing further support to our results
here in the cortex and hippocampus.
The attenuation of run down of fEPSPs by glutamine in both
hippocampal Schaffer collateral and the neocortical layer I prep-
arations suggests that the local synaptic glutamate-glutamine
cycle may be common to excitatory synapses of projection neu-896 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.rons throughout the mammalian CNS. The marked difference in
the rates of fEPSP depression in control conditions (cf. Figures
2B and 6C), despite the similar time course for fEPSP depression
in MSO (cf. Figures 4B and 6D), suggests a regional variability in
the glutamate-glutamine cycle. Interestingly, the number of syn-
apses contacted by each astrocyte is four times higher in the hip-
pocampus than in neocortex (Bushong et al., 2002; Halassa
et al., 2007), indicating that the synapse/astrocyte ratio may
define the capacity of the local glutamate-glutamine cycle and
the capacity for sustained high-frequency synaptic activity.
Our initial experiments, and those of others (Kam and Nicoll,
2007; Masson et al., 2006), suggest that synaptic transmission
during LFS is completely independent of the cycle. Although
the glutamate-glutamine cycle is the primary mechanism for
recycling released glutamate (Bergles and Jahr, 1998), there is
evidence for presynaptic uptake of glutamate and expression
of the Na+-dependent excitatory amino acid transporter GLT1
in Schaffer collaterals (Furness et al., 2008; Gundersen et al.,
1993). However, the minimal recovery of fEPSPs of the MSO-
treated slices following iHFS suggests that the contribution
from precursors other than glutamine and direct presynaptic
glutamate reuptake cannot maintain the glutamate neurotrans-
mitter pool even during periods of low-frequency activity. A
possible explanation for the absence of run down with LFS
is that in the acutely isolated brain slice, there is a large
A B
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Figure 8. Minimally Evoked Natural Stimulus Pattern Reveals Gluta-
mine-Dependent Reduction in Evoked Synaptic EPSCs
EPSC amplitudes were analyzed from intracellular recordings of CA1 cells in
which the Schaffer collaterals were minimally stimulated with natural patterns
in the absence or presence of glutamine.
(A) Representative example of averaged minimally evoked EPSC amplitudes
(upper panel) during 0.2 Hz stimulation from a CA1 cell over 5 min during
baseline (left), the first 5 min post-nLFS (middle), and 10–15 min post-nLFS
(right). Red dotted line represents mean baseline amplitude. Relative ampli-
tudes of evoked EPSCs from 13 individual cells (middle panel) during baseline,
the first 5 min post-nLFS (Poststim), and 10–15 min post-nLFS (recovery) are
shown. Red continuous line depicts representative median response corre-
sponding to the representative traces. Time course of evoked EPSC ampli-
tudes from a representative cell normalized to the median of the baseline is
shown (bottom panel). Blue bar represents duration of natural stimulus.
(B–D) Same as above but with (B) nLFS in glutamine (n = 11), (C) nHFS in aCSF
(n = 13), and (D) nHFS in glutamine (n = 11). A significant reduction of evoked
EPSCs was seen with nHFS in aCSF during poststim (0.65 median; **p < 0.05)
and recovery (0.58 median; **p < 0.05), but not in glutamine (one-way ANOVA;
aCSF p = 0.0134, glutamine p = 0.9125 for differencewithin groups). Therewas
no significant difference in evoked EPSCs with nLFSwith or without glutamine.
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Glu/Gln Cycle Sustains Excitatory Transmissionglutamate/glutamine reservoir that feeds into the neurotrans-
mitter supply. This explanation is supported by our finding that
the effect of MSO is only evident after 1,000 stimuli at both 2
and 20 Hz stimulation.
If there is such a large supply of glutamate and glutamine avail-
able, is there any role for regulation of the glutamate-glutamine
cycle in synaptic plasticity? Reduced synaptic efficacy associ-
ated with high-frequency stimulation is a well-established phe-
nomenon (Collingridge et al., 2010). The depletion of glutamate
available for release that we describe may explain a portion
of short-term synaptic depression associated with prolonged
high-frequency stimulation (Garcia-Perez et al., 2008; Stevens
and Wesseling, 1999; Wesseling and Lo, 2002). Our iHFS para-
digm likely creates a neurotransmitter supply demand similar
to normal physiological phenomena including bursts of 20–
30 Hz oscillations lasting many tens of seconds in the hippo-
campi of mice exploring novel environments (Berke et al.,
2008; Hermann et al., 2007; Taberner and Liberman, 2005). Inter-
estingly, compared to a continuous intense stimulus such as
high potassium, intermittent high-frequency activity likely leads
to greater amounts of neurotransmitter release because the
periods of low-frequency activity allow for recovery of the releas-
able vesicle pool that is rapidly depleted during intense stimula-
tion (Sara et al., 2002). This may explain, in part, previous reports
of sustained excitatory neurotransmission during intense stimu-
lation (Kam and Nicoll, 2007; Masson et al., 2006). Furthermore,
the high-frequency natural stimulus pattern led to a glutamine-
dependent run down in synaptic efficacy that paralleled what
we observed with iHFS. The mean firing frequency of the nHFS
pattern corresponds to the range of firing rates for place cells
in field, whereas the nLFS that did not lead to a run down in effi-
cacy corresponds to the low end of activity of place cells in the
field (Mizuseki and Buzsa´ki, 2013) and similar to the average
firing rate of CA3 cells recorded during rapid eye movement
(REM) sleep (Mizuseki et al., 2012). The level of activity in our
nHFS pattern is maintained in vivo much longer than replayed
in our experiment, and because these recordings were from
rodents running laps in a familiar environment without novel
cues, the mean firing frequency in a novel environment may be
even greater (Berke et al., 2008).
The mechanisms underlying the reduced synaptic efficacy
with neurotransmitter depletion may involve both a reduction in
release probability and a reduction in quantal size. The reduction
in the amplitude of evoked responses with minimal stimulation
after nHFS suggests a reduction in the amount of glutamate
release with single synaptic events, consistent with previous
findings of reduced synaptic event amplitudes with disruption
of the glutamate-glutamine cycle (Bonansco et al., 2011; Tani
et al., 2010). Recent work has demonstrated that the recycling
vesicle pool size and release probability at GABAergic synapses
are reduced when cytosolic neurotransmitter supply is limited
(Wang et al., 2013). This is consistent with previous studies
of cholinergic synapses (Poulain et al., 1986) and with our find-
ings of an increased paired-pulse ratio in MSO-treated slices
after iHFS.
Although our data suggest that concentrations of glutamine in
CSF provide a buffer, recent findings indicate that high-fre-
quency stimulation in vivo can reduce glutamine concentrationNeuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc. 897
Neuron
Glu/Gln Cycle Sustains Excitatory Transmissionat nerve terminals (Jenstad et al., 2009), suggesting that the
capacity of the glutamate-glutamine cycle may provide a ceiling
for the rate at which glutamate is released at excitatory synap-
ses. The regulation of cycle components including system N
transporters and GS may therefore provide a novel mechanism
for altering synaptic efficacy in normal and diseased states
(Balkrishna et al., 2010; Dai et al., 2012; Nissen-Meyer et al.,
2011; Sidoryk-Wegrzynowicz et al., 2011).EXPERIMENTAL PROCEDURES
Preparation of Brain Slices
Briefly, following all guidelines of Stanford University’s Institutional Animal
Care and Use Committee, Sprague-Dawley rats (3–8 weeks) were anesthe-
tized (55 mg/kg pentobarbital through intraperitoneal injection), decapitated,
and the brains were rapidly removed and placed in chilled (4C) low-Ca,
low-Na+ slicing solution consisting of 234 mM sucrose, 11 mM glucose,
24 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 10 mM MgSO4, and
0.5 mM CaCl2, equilibrated with a mixture of 95% O2 and 5% CO2. The brain
was glued to the slicing stage of a Leica VT1200 sectioning system, and slices
(350 mm) were cut in a coronal orientation. The slices were then incubated for
1 hr in 32C oxygenated aCSF consisting of 126 mM NaCl, 26 mM NaHCO3,
3 mMKCl, 1.25 mMNaH2PO4, 2 mMMgCl2, 2 mMCaCl2, and 10mM glucose.
For hippocampal slices, a transaction was made between CA1 and CA3 with a
scalpel blade while the sectioned brain was in cold cutting solution.
Field Recordings
Hippocampus
Slices were placed in an interface chamber maintained at 32C–34C and
superfused with oxygenated aCSF at 2 ml/min and stimulated with a concen-
tric bipolar electrode at Schaffer collaterals with 20–100 mA pulses of 100 ms
duration at 0.2 Hz (unless otherwise indicated) delivered by a stimulus isolator
(World Precision Instruments). Stimulus current was adjusted to induce an FV
amplitude of 0.15 mV (±0.05 mV) during the baseline period of the experiment
and was maintained at this level throughout the experiment except during I/O
curve measurements. The I/O curve was normalized to the highest stimulus in-
tensity tested (0.3mV FV amplitude). For each slice, two stimulating electrodes
were placed on either side of the recording electrode, with slight displacement
to ensure stimulation of nonoverlapping parallel Schaffer collateral pathways.
Displacement position and stimulus sides were randomly altered between
slices. During 0.2 Hz baseline data acquisition, the stimulation of the test
(iHFS) pathway was interleaved with the stimulation of the control (no HFS)
pathway 2.5 s apart.
Cortex
Slices were placed in an interface chamber with oxygenated aCSF and
transected vertically from layer II to the subcortical white matter and then
horizontally below layer I on one side of the vertical cut in aCSF with
10 mMMg. The slice was then superfused with oxygenated aCSF at 2 ml/min
with D-APV (50 mM). The isolated layer I fibers were stimulated with a
concentric bipolar electrode with 20–100 mA pulses of 100 ms duration at
0.2 Hz, or as indicated.
aCSF contained 50 mM D-APV or 100 mM DL-APV with or without 500 mM
glutamine as indicated. For MSO experiments, individual slices were incu-
bated in freshly prepared 5mMMSO in oxygenated aCSF for 1 hr at room tem-
perature. We have previously shown that this treatment leads to a greater than
75% reduction in glutamine content in the slice (Tani et al., 2010). The slices
were then transferred onto the recording rig in indicated aCSF solutions
without MSO.
Electrophysiological data were recorded from glassmicropipette electrodes
1 MU filled with aCSF using an Axon Multiclamp 700A amplifier and Digidata
1322A digitizer with pClamp software (Molecular Devices). Slices with more
than 40% change in FV amplitude during recording were discarded from anal-
ysis. Slices were also excluded from analysis if a spreading depression-like
event, defined as a concurrent and significant unprovoked change in evoked
fEPSPs from both stimulating electrodes, occurred.898 Neuron 81, 888–900, February 19, 2014 ª2014 Elsevier Inc.Natural Stimulus Pattern
Twelveminutes of in vivo unit recordings from two CA3 pyramidal cells from an
adult male Long-Evans rat running laps in a linear track field (as described in
Mizuseki et al., 2009) were converted to time-stamped stimulus patterns
(100 ms per event), which was then played back as waveform patterns in
100 s segments sequentially in Clampex to drive two stimulators simulta-
neously while recording from a single recording electrode. Predefined tempo-
ral patterns allowed discrimination of nLFS and nHFS postanalysis.
Whole-Cell Recordings
Whole-cell voltage-clamp recordings were made from CA1 pyramidal cells
using 2–5 MU pipettes filled with a solution containing 120 mM K gluconate,
10 mM HEPES, 11 mM KCl, 1 mM MgCl2, 11 mM EGTA, and 1 mM CaCl2
(pH 7.3). During EPSC recordings, the CA1 cell membrane was clamped
at 57.7 mV, and pharmacologically isolated AMPA currents were recorded
by bath application of the GABAA receptor antagonist picrotoxin (50 mM;
Tocris) and NMDA receptor antagonist (D-APV, 50 mM); access resistance
was monitored at the beginning and end of the recordings, and only cells
with stable access resistance were included in the analysis. Stimulation setup
was the same as for field potential recordings. A modified minimal stimulation
approach based on Dobrunz and Stevens (1997) was used. Briefly, pulse pairs
(40 ms interval) were applied at 0.2 Hz while adjusting stimulus strength to find
conditions of minimal stimulation. The stimulus current was varied until a
range of current was found for which three parameters were met: the EPSC
amplitude remained constant, failures were observed, and a small reduction
in stimulus amplitude resulted in 100% failures. Typically, this range was
10–50 pA.
For evoked EPSCs, a low-pass Gaussian filter was used at 1 kHz to reduce
signal-to-noise ratio, and the amplitudes were calculated as the maximum
peak-to-baseline value. Values smaller than 5 pA that were indistinguishable
from noise were considered failures and were not included in the analysis
of evoked EPSC amplitude. Failure rate was assessed and found to be
unchanged in each condition (data not shown). Average raw amplitude values
in each condition were not significantly different from one another and ranged
from 20 to 26 pA. Normality was assessed by performing the Shapiro-Wilk
normality test and statistical significance by performing one-way ANOVA or
Kruskal-Wallis one-way ANOVA on Ranks.
Biosensor Imaging
Glutamate biosensor data were collected and analyzed as previously
described (Dulla et al., 2008). Briefly, 50 ml of FLII81E-1 mMFRET-based gluta-
mate biosensor protein (50 ng/ml) was applied to the slice on a 35 mm culture
dish filled with 2 ml aCSF in a humidified chamber. After 10–20 min of incuba-
tion, the slice was placed into the recording chamber for simultaneous imaging
and electrophysiological recording (Dulla et al., 2008). The slice was illumi-
nated with 440 nm light, and CFP (426–446 nm range) and Venus (505–
565 nm range) signals were imaged at 500 Hz with a RedShirt Neuro-CCD
camera. Ratiometric glutamate biosensor movies were collected during ten
successive stimulations and adjusted for bleaching using an exponential
decay and then averaged. From the averaged movie, an integrated glutamate
response was generated by summing 30 frames of baseline-subtracted data.
The region of biosensor signal change was determined by threshold analysis.
Briefly, all pixels with an integrated change in FRET of <0.001 were discarded,
and the remaining pixels were ranked based on intensity. The pixels with the
90th–100th percentile most-intense signal were selected, and stray pixels
were eliminated using an erosion filter. This region of interest was then used
to analyze the FRET ratio for each individual glutamate movie, and the
response (DFRET ratio) was averaged for all ten movies. In order to generate
representative images for each response, the DFRET images were blanked
outside of the region of interest and overlaid on a bright-field image of the
isotopic area.
Drugs and Reagents
All salts and glucose for use in buffers were obtained from Sigma-Aldrich. In
addition, the following reagents were also obtained from Sigma-Aldrich:
L-MSO (M5379) and L-glutamine (G3126). g-DGG (ASC-307), D-APV (ASC-
003), and DL-APV (ASC-004) were obtained from Ascent Scientific.
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Data recorded by pClamp were analyzed using Clampfit software (Molecular
Devices), as well as with in-house software written in MATLAB. Relative
changes in fEPSP amplitudes and area were analyzed as indicated.
Statistics
Unless otherwise indicated, statistical significance for all experiments was
determined using Student’s unpaired and paired t tests as well as ANOVA,
as appropriate.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at http://dx.doi.org/10.1016/j.neuron.2013.12.026.
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